1h Free Analyst Time
The Solubility Enhancement Excipients Market size was estimated at USD 3.63 billion in 2023, USD 3.82 billion in 2024, and is expected to grow at a CAGR of 5.62% to reach USD 5.33 billion by 2030. Speak directly to the analyst to clarify any post sales queries you may have.
Solubility enhancement excipients are a specific category of pharmaceutical ingredients used primarily in the drug manufacturing process to increase the solubility of poorly soluble drug compounds. They play a critical role in bioavailability enhancement, facilitating the dissolution of drugs into the body and thus increasing their therapeutic effectiveness. The rise in chronic diseases and increase in drug discovery and development are accelerating the need for solubility enhancement excipients from the pharmaceutical industries. However, volatility in raw material cost and stringent regulations may adversely impact the use of solubility enhancement excipients by the end-use sectors. Moreover, the proliferation of nanotechnology, the incorporation of bio-based excipients, and the development of multifunctional excipients are expected to create immense potential for the growth of solubility enhancement excipients worldwide.
Regional Insights
The solubility enhancement excipients market is evolving in the Americas owing to the well-established pharmaceutical industries, innovations in drug formulation, and technological advancements in drug manufacturing. The Asia Pacific is witnessing significant demand for solubility enhancement excipients due to the increasing prevalence of chronic diseases, the surge in research and development activities, and high generic drug production. Europe, Middle East, and Africa (EMEA) represent high demand for solubility enhancement excipients with strong research and development foundations, ongoing development of novel excipients used in oral administration, and expanding healthcare infrastructure. Besides, technological advancements in the manufacturing of solubility enhancement excipients and ongoing research to improve their properties are anticipated to expand the use of solubility enhancement excipients across the end-use sectors globally.FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Solubility Enhancement Excipients Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Solubility Enhancement Excipients Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.Key Company Profiles
The report delves into recent significant developments in the Solubility Enhancement Excipients Market, highlighting leading vendors and their innovative profiles. These include ABITEC Corporation, Air Liquide S.A., Ashland Global Holdings Inc., BASF SE, Cargill, Incorporated, Clariant International Ltd., Croda International PLC, DuPont de Nemours Inc., Evonik Industries AG, FMC Corporation, FREUND Corporation, Gattefossé, IMCD Group, JRS Pharma GmbH & Co. KG, Kerry Group PLC, Lubrizol Corporation, Merck KGaA, Nippon Soda Co. Ltd., Pharma Excipients International AG, Roquette Freres SA, Shin-Etsu Chemical Co., Ltd., Solvay SA, SPI Pharma Inc., The DOW Chemical Company, and Wacker Chemie AG.Market Segmentation & Coverage
This research report categorizes the Solubility Enhancement Excipients Market to forecast the revenues and analyze trends in each of the following sub-markets:- Product
- Particle Size Reduction
- Solid Dispersion
- Type
- Lipid
- Polymer
- Surfactant
- Application
- Hospitals
- Pharmaceuticals
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
The report offers valuable insights on the following aspects:
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
- What is the market size and forecast of the Solubility Enhancement Excipients Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Solubility Enhancement Excipients Market?
- What are the technology trends and regulatory frameworks in the Solubility Enhancement Excipients Market?
- What is the market share of the leading vendors in the Solubility Enhancement Excipients Market?
- Which modes and strategic moves are suitable for entering the Solubility Enhancement Excipients Market?
Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report
Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.
This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.
Table of Contents
1. Preface
2. Research Methodology
4. Market Overview
5. Market Insights
6. Solubility Enhancement Excipients Market, by Product
7. Solubility Enhancement Excipients Market, by Type
8. Solubility Enhancement Excipients Market, by Application
9. Americas Solubility Enhancement Excipients Market
10. Asia-Pacific Solubility Enhancement Excipients Market
11. Europe, Middle East & Africa Solubility Enhancement Excipients Market
12. Competitive Landscape
13. Competitive Portfolio
14. Appendix
List of Figures
List of Tables
Companies Mentioned
- ABITEC Corporation
- Air Liquide S.A.
- Ashland Global Holdings Inc.
- BASF SE
- Cargill, Incorporated
- Clariant International Ltd.
- Croda International PLC
- DuPont de Nemours Inc.
- Evonik Industries AG
- FMC Corporation
- FREUND Corporation
- Gattefossé
- IMCD Group
- JRS Pharma GmbH & Co. KG
- Kerry Group PLC
- Lubrizol Corporation
- Merck KGaA
- Nippon Soda Co. Ltd.
- Pharma Excipients International AG
- Roquette Freres SA
- Shin-Etsu Chemical Co., Ltd.
- Solvay SA
- SPI Pharma Inc.
- The DOW Chemical Company
- Wacker Chemie AG
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 193 |
| Published | March 2024 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 3.82 Billion |
| Forecasted Market Value ( USD | $ 5.33 Billion |
| Compound Annual Growth Rate | 5.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 25 |
